1. Home
  2. ATOM vs IMUX Comparison

ATOM vs IMUX Comparison

Compare ATOM & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Atomera Incorporated

ATOM

Atomera Incorporated

HOLD

Current Price

$3.07

Market Cap

157.7M

Sector

Technology

ML Signal

HOLD

Logo Immunic Inc.

IMUX

Immunic Inc.

BUY

Current Price

$6.87

Market Cap

155.8M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ATOM
IMUX
Founded
2001
2016
Country
United States
United States
Employees
N/A
66
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.7M
155.8M
IPO Year
2016
2013

Fundamental Metrics

Financial Performance
Metric
ATOM
IMUX
Price
$3.07
$6.87
Analyst Decision
Strong Buy
Analyst Count
0
12
Target Price
N/A
★ $43.09
AVG Volume (30 Days)
★ 421.7K
417.3K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
4.41
★ 38.00
EPS
★ N/A
N/A
Revenue
★ $62,000.00
N/A
Revenue This Year
$361.54
N/A
Revenue Next Year
$233.33
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$1.89
$0.51
52 Week High
$12.37
$17.43

Technical Indicators

Market Signals
Indicator
ATOM
IMUX
Relative Strength Index (RSI) 24.32 28.28
Support Level $2.26 $0.83
Resistance Level $3.51 $8.60
Average True Range (ATR) 0.23 0.69
MACD -0.11 0.04
Stochastic Oscillator 2.13 17.84

Price Performance

Historical Comparison
ATOM
IMUX

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used in the semiconductor industry. The company's silicon technology can be used for applications like Analog, DRAM, logic, processors, and SRAM. Geographically, it generates maximum revenue from North America.

About IMUX Immunic Inc.

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.

Share on Social Networks: